Michelle Carr, Author at BioTuesdays

Developments

Soliton files 510(k) for RAP device approval to reduce cellulite

Soliton (NASDAQ:SOLY) filed for 510(k) premarket clearance with the FDA of its second generation Rapid Acoustic Pulse (RAP) device for the reduction in the appearance of cellulite. The 510(k) filing is based on results...

July 1, 2020

Developments

Texas A&M video series features iBio COVID-19 vaccines

iBio’s (NYSE American:IBIO) two COVID-19 vaccine candidates were featured on the final episode of the video series, “COVID-19: The Texas A&M University System Responds.” “This is an important collaboration,” John...

June 26, 2020

Developments

IBM Watson Health selects iBio to support COVID-19 vaccine candidates

IBM Watson Health selected iBio (NYSE American:IBIO) to receive 18 months use of the IBM clinical development (ICD) solution at no cost. IBM Watson Health recently began offering its clinical development solution to...

June 24, 2020

Developments

Stereotaxis to be added to the Russell 2000 and Russell 3000 indexes

Stereotaxis (NYSE: STXS) will be added to the Russell 2000 and Russell 3000 indexes after the close on June 26, as part of the Russell indexes annual reconstitution. “This is another step forward in our effort to...

June 22, 2020

Developments

Kamada IgG therapy cleared for compassionate COVID-19 use in Israel

Kamada (NASDAQ, TASE:KMDA) completed manufacturing of the first batch of its plasma-derived immunoglobulin (IgG) product for the treatment of COVID-19 and the initial vials are available for compassionate use in Israel...

June 17, 2020

Developments

Analysts see EAU data broadening utility of Profound Medical’s TULSA-PRO

Analysts for Raymond James and Cowen say two posters to be presented at the European Association of Urology (EAU) virtual conference in mid-July enhance the clinical utility of Profound Medical’s (NASDAQ:PROF;...

June 11, 2020

Developments

IntelGenx receives Health Canada cannabis micro-processing license

IntelGenx (TSXV:IGX; OTCQB:IGXT) received a cannabis micro-processing license from Health Canada under the Cannabis Act and Cannabis Regulations for the company’s Montreal, Quebec facility. “Receipt of this cannabis...

June 8, 2020

Developments

PharmAust lab tests show positive signs for suppressing COVID-19

PharmAust (ASX:PAA) posted positive preliminary results in experiments aimed at inhibiting the virus that causes COVID-19. PharmAust, which traditionally is focused on repurposing existing drugs for cancer therapy, is...

June 4, 2020

Developments

Study with Daxor BVA-100 published in Circulation

Blood volume outcome data has been published in the American Heart Association journal, Circulation, utilizing Daxor’s (NYSE American:DXR) BVA-100 blood volume measurement device to determine the primary endpoint...

May 22, 2020

Markets

Brookline starts Biocept at buy; PT $2.06

Brookline Capital Markets initiated coverage of Biocept (NASDAQ:BIOC) with a “buy” rating and price target of $2.06. The stock closed at 44 cents on May 13. Biocept is a molecular oncology diagnostics company that...

May 14, 2020

Author - Michelle Carr

Soliton files 510(k) for RAP device approval to reduce cellulite

Texas A&M video series features iBio COVID-19 vaccines

IBM Watson Health selects iBio to support COVID-19 vaccine candidates

Stereotaxis to be added to the Russell 2000 and Russell 3000 indexes

Kamada IgG therapy cleared for compassionate COVID-19 use in Israel

Analysts see EAU data broadening utility of Profound Medical’s TULSA-PRO

IntelGenx receives Health Canada cannabis micro-processing license

PharmAust lab tests show positive signs for suppressing COVID-19

Study with Daxor BVA-100 published in Circulation

Brookline starts Biocept at buy; PT $2.06

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter